Literature DB >> 3338039

Prognostication in soft tissue sarcoma. A model with four risk factors.

B Rööser1, R Attewell, N O Berg, A Rydholm.   

Abstract

A multivariate analysis of risk factors for death due to tumor was performed in 82 patients with highly malignant, histologic Grades III and IV primary soft tissue sarcoma of the locomotor system. All the patients had been operated on with a wide or radical surgical margin. Male sex, histologic malignancy Grade IV, extensive tumor necrosis, and tumor size greater than 10 cm were identified as risk factors. Patients with no or one risk factor had a 6(10)-year survival rate of 100% (100%), equal to 96% (96%) in a group with Grade I and Grade II tumors operated on with the same margin. These two groups comprised 50% of all the patients operated on with a wide or radical margin. The 6(10)-year survival rate decreased to 75% (75%) for patients with two risk factors and to 33% (22%) for patients with three or four risk factors. The risk factor model also applied to 62 patients operated on with marginal surgery; and for patients with three or four risk factors, more extensive surgery only had a small effect on long-term survival. The model could be of value when eligibility criteria for trials with adjunctive chemotherapy are determined.

Entities:  

Mesh:

Year:  1988        PMID: 3338039     DOI: 10.1002/1097-0142(19880215)61:4<817::aid-cncr2820610429>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Socioeconomic status and survival from soft-tissue sarcomas: a population-based study in northern Italy.

Authors:  G Ciccone; C Magnani; L Delsedime; P Vineis
Journal:  Am J Public Health       Date:  1991-06       Impact factor: 9.308

2.  Assessing prognosis for high-grade soft-tissue sarcomas: search for a marker.

Authors:  X Q Li; S G Parkekh; A E Rosenberg; H J Mankin
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

3.  Outcomes in patients with popliteal sarcomas.

Authors:  Robert E Turcotte; Marco Ferrone; Marc H Isler; Cynthia Wong
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

4.  Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation.

Authors:  N A Janjan; A W Yasko; G P Reece; M J Miller; J A Murray; M I Ross; M M Romsdahl; M J Oswald; T G Ochran; R E Pollock
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

5.  Prediction of survival in patients with high-grade soft tissue sarcoma.

Authors:  B Rööser; N O Berg; J Ranstam; A Rydholm; H Willén
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

6.  Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas.

Authors:  Walter Rhomberg; Helmut Eiter; Franz Schmid; Christoph H Saely
Journal:  Clin Exp Metastasis       Date:  2007-10-12       Impact factor: 5.150

7.  Prognostic factors for survival in soft tissue sarcoma.

Authors:  J N el-Jabbour; S S Akhtar; G R Kerr; K M McLaren; J F Smyth; A Rodger; R C Leonard
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Prognostic significance of histological invasion in high grade soft tissue sarcomas.

Authors:  Satoshi Tsukushi; Yoshihiro Nishida; Hiroshi Urakawa; Eiji Kozawa; Naoki Ishiguro
Journal:  Springerplus       Date:  2014-09-22

9.  Sarcomas in north west England: III. Survival.

Authors:  A L Hartley; V Blair; M Harris; J M Birch; S S Banerjee; A J Freemont; J McClure; L J McWilliam
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

10.  Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.

Authors:  Keith M Skubitz; Stefan Pambuccian; J Carlos Manivel; Amy P N Skubitz
Journal:  J Transl Med       Date:  2008-05-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.